Lubiprostone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lubiprostone
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Lubiprostone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 12 USDMF, 4 JDMF, 2 EU WC, 7 NDC API, 10 Listed Suppliers, $ API Reference Price

19 API Suppliers
12 USDMF
4 JDMF
2 EU WC
7 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 12 FDA Orange Book

12 FDF Dossiers
12 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 24MCG, CAPSULE;ORAL - 8MCG

CAPSULE;ORAL - 24MCG
CAPSULE;ORAL - 8MCG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 6 DKSH, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 1 BASF, 1 Gangwal Chemicals, 3 Lonza Capsugel, 1 Qualicaps, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

1 Rochem International Inc
2 SPI Pharma
6 DKSH
1 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 ACG Worldwide
1 BASF
1 Gangwal Chemicals
3 Lonza Capsugel
1 Qualicaps
11 Roquette
1 Shijiazhuang Huaxu Pharmaceutical
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 8 Empty Capsules, 8 Fillers, Diluents & Binders, 7 Coating Systems & Additives, 5 Taste Masking, 4 Thickeners and Stabilizers, 2 Chewable & Orodispersible Aids, 2 Coloring Agents, 2 Parenteral, 1 Solubilizers, 1 Topical, 1 Co-Processed Excipients, 1 Direct Compression, 1 Soft Gelatin

9 Film Formers & Plasticizers
8 Empty Capsules
8 Fillers, Diluents & Binders
7 Coating Systems & Additives
5 Taste Masking
4 Thickeners and Stabilizers
2 Chewable & Orodispersible Aids
2 Coloring Agents
2 Parenteral
1 Solubilizers
1 Topical
1 Co-Processed Excipients
1 Direct Compression
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 16 Annual Reports

2 US Medicaid Prescriptions
16 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

9 US Patents, 4 Health Canada Patents

9 US Patents
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 776,985 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Kirby Eades Gale Baker

filter Patent Reset all filters

4 All

01 12385732

02 12419741

03 12464420

04 12637274

filter Product Reset all filters

4 All

01 4LUBIPROSTONE

filter Dosage Reset all filters

4 All

01 4CAPSULE

filter Exp Date Reset all filters

4 All

01 12020-10-13

02 12021-09-04

03 12022-11-14

04 12027-01-23

Chirogate Lubiprostone

Product Main Page

01

Kirby Eades Gale Baker

Lubiprostone

Antibody Engineering

Not Confirmed

Kirby Eades Gale Baker

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-10-13

Date Granted : 2009-02-10

Lubiprostone

Brand Name : AMITIZA

Patent Number : 2385732

Filing Date : 2000-10-13

Strength per Unit : 24 mcg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-10-13

Date Granted : 2009-02-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Kirby Eades Gale Baker

Lubiprostone

Antibody Engineering

Not Confirmed

Kirby Eades Gale Baker

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-09-04

Date Granted : 2010-11-30

Lubiprostone

Brand Name : AMITIZA

Patent Number : 2419741

Filing Date : 2001-09-04

Strength per Unit : 24 mcg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-09-04

Date Granted : 2010-11-30

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Kirby Eades Gale Baker

Lubiprostone

Antibody Engineering

Not Confirmed

Kirby Eades Gale Baker

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-11-14

Date Granted : 2011-12-13

Lubiprostone

Brand Name : AMITIZA

Patent Number : 2464420

Filing Date : 2002-11-14

Strength per Unit : 24 mcg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-11-14

Date Granted : 2011-12-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Kirby Eades Gale Baker

Lubiprostone

Antibody Engineering

Not Confirmed

Kirby Eades Gale Baker

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-01-23

Date Granted : 2013-06-04

Lubiprostone

Brand Name : AMITIZA

Patent Number : 2637274

Filing Date : 2007-01-23

Strength per Unit : 24 mcg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-01-23

Date Granted : 2013-06-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?